Effect of Interventions on Progression of Knee Osteoarthritis - a Comparison of Effect of Glucosamine/Chondroitin or Diacerin Vs Placebo: Measured by Clinical, Radiological and Biochemical Parameters
Phase of Trial: Phase IV
Latest Information Update: 07 Mar 2018
Price : $35 *
At a glance
- Drugs Diacerein (Primary) ; Glucosamine/chondroitin sulfate
- Indications Osteoarthritis
- Focus Therapeutic Use
- Acronyms KAPS
- 28 Feb 2018 Status changed from active, no longer recruiting to completed.
- 09 Mar 2017 Planned primary completion date changed from 1 Aug 2017 to 1 Jul 2017.
- 24 Feb 2016 Planned End Date changed from 1 Sep 2017 to 1 Oct 2017 as reported by ClinicalTrials.gov.